Fabry patients wear tech to uncover hidden links between activity, sleep, and Well-Being
NCT ID NCT06484478
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study monitored 100 adults with Fabry disease using a wearable device and questionnaires to measure physical activity, sleep, and quality of life. The goal was to understand how daily movement and rest relate to anxiety, depression, and overall well-being. No treatment was given; the study simply collected real-world data to guide future care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal links between daily activity, sleep, and mental health in Fabry disease, pointing toward lifestyle-based support strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to all Fabry patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
100 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults with Fabry disease who meet the eligibility criteria.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of Fabry disease documented by genotyping and/or enzymatic analysis. * Resident in the UK. * Aged 18 years and over. * Capable of providing informed consent. * Physically able to stand and ambulate independently. Exclusion Criteria: * A known allergy to any materials in the wearable device. * Not able to have or use a wearable. * Taking part in an interventional study which would preclude real-world data collection. * Unable to communicate in English to a sufficient level to permit engagement in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fabry disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Free London NHS Foundation Trust
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a One-Time gene therapy fix fabry disease for years?
- Can a new pill stop fatty buildup in fabry disease?
- Gene Therapy's lasting promise: can one infusion safely control fabry disease for years?
- Can early enzyme therapy save kidneys in fabry disease?
- Can continued lucerastat access help fabry patients?
- Can a single gene infusion rewrite the story of fabry disease?